Viewing Study NCT00121095


Ignite Creation Date: 2025-12-24 @ 2:12 PM
Ignite Modification Date: 2025-12-27 @ 7:00 AM
Study NCT ID: NCT00121095
Status: UNKNOWN
Last Update Posted: 2007-12-21
First Post: 2005-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Sponsor: Cytogen Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module